JP2003102471A - 調節性ｔ細胞の分化誘導・増殖促進方法 - Google Patents

調節性ｔ細胞の分化誘導・増殖促進方法

Info

Publication number
JP2003102471A
JP2003102471A JP2001305588A JP2001305588A JP2003102471A JP 2003102471 A JP2003102471 A JP 2003102471A JP 2001305588 A JP2001305588 A JP 2001305588A JP 2001305588 A JP2001305588 A JP 2001305588A JP 2003102471 A JP2003102471 A JP 2003102471A
Authority
JP
Japan
Prior art keywords
cells
cell
regulatory
antibody
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001305588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003102471A5 (enExample
Inventor
Junichi Masuyama
純一 益山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Original Assignee
Kirin Brewery Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd filed Critical Kirin Brewery Co Ltd
Priority to JP2001305588A priority Critical patent/JP2003102471A/ja
Priority to US10/122,432 priority patent/US20030064067A1/en
Publication of JP2003102471A publication Critical patent/JP2003102471A/ja
Publication of JP2003102471A5 publication Critical patent/JP2003102471A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2001305588A 2001-10-01 2001-10-01 調節性ｔ細胞の分化誘導・増殖促進方法 Pending JP2003102471A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2001305588A JP2003102471A (ja) 2001-10-01 2001-10-01 調節性ｔ細胞の分化誘導・増殖促進方法
US10/122,432 US20030064067A1 (en) 2001-10-01 2002-04-16 Method for inducing differentiation and promoting proliferation of regulatory T cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001305588A JP2003102471A (ja) 2001-10-01 2001-10-01 調節性ｔ細胞の分化誘導・増殖促進方法

Publications (2)

Publication Number Publication Date
JP2003102471A true JP2003102471A (ja) 2003-04-08
JP2003102471A5 JP2003102471A5 (enExample) 2005-06-16

Family

ID=19125354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001305588A Pending JP2003102471A (ja) 2001-10-01 2001-10-01 調節性ｔ細胞の分化誘導・増殖促進方法

Country Status (2)

Country Link
US (1) US20030064067A1 (enExample)
JP (1) JP2003102471A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087210A1 (ja) * 2003-03-31 2004-10-14 Kirin Beer Kabushiki Kaisha 抗cd52抗体による調節性t細胞分化誘導･増殖方法およびそのための医薬組成物
WO2005094886A1 (ja) * 2004-03-31 2005-10-13 Kirin Beer Kabushiki Kaisha Gpiアンカー蛋白質アゴニストによる調節性t細胞分化誘導・増殖方法およびそのための医薬組成物
JP2009508089A (ja) * 2005-08-02 2009-02-26 センテナリ インスティチュート オブ キャンサー メディシン アンド セル バイオロジー 調節性ｔ細胞を同定する方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
WO2006133398A2 (en) * 2005-06-08 2006-12-14 Invitrogen Corporation In vitro activated donor t-cells to promote transplant engraftment
US9315382B2 (en) 2006-03-23 2016-04-19 Keystone Metals Recovery Inc. Metal chlorides and metals obtained from metal oxide containing materials
US10092597B2 (en) 2014-01-14 2018-10-09 The University Of Hong Kong Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858358A (en) * 1992-04-07 1999-01-12 The United States Of America As Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of T cells
JP3593032B2 (ja) * 1997-09-10 2004-11-24 純一 益山 ヒト単核球に対するモノクローナル抗体

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087210A1 (ja) * 2003-03-31 2004-10-14 Kirin Beer Kabushiki Kaisha 抗cd52抗体による調節性t細胞分化誘導･増殖方法およびそのための医薬組成物
WO2005094886A1 (ja) * 2004-03-31 2005-10-13 Kirin Beer Kabushiki Kaisha Gpiアンカー蛋白質アゴニストによる調節性t細胞分化誘導・増殖方法およびそのための医薬組成物
JP2009508089A (ja) * 2005-08-02 2009-02-26 センテナリ インスティチュート オブ キャンサー メディシン アンド セル バイオロジー 調節性ｔ細胞を同定する方法

Also Published As

Publication number Publication date
US20030064067A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
US8389016B2 (en) Use of a CD28 binding substance for making a pharmaceutical composition
JP5184732B2 (ja) Ｔ細胞亜集団に特異的なモノクローナル抗体およびポリクローナル抗体の組成物および使用方法
Nakamura et al. Cell contact–dependent immunosuppression by CD4+ CD25+ regulatory T cells is mediated by cell surface–bound transforming growth factor β
EP2893002B1 (en) Methods of expanding and assessing b cells and using expanded b cells to treat disease
EP1648507A1 (en) Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds
US20090232854A1 (en) Uses of bispecific antibody coated dendritic cells pulsed with antigens and gm-csf in immune regulation
TW201000130A (en) Anti-CD8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory CD8+ T cells
WO2005033301A1 (ja) 細胞活性化方法及びこれを用いる細胞製造方法並びに医薬組成物
EP1749538A1 (en) Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor
JP2003102471A (ja) 調節性ｔ細胞の分化誘導・増殖促進方法
EP1618891A1 (en) Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor
Gorczynski et al. Specificity for in vivo graft prolongation in gamma delta T cell receptor+ hybridomas derived from mice given portal vein donor-specific preimmunization and skin allografts
JP2003534283A (ja) 天然で誘導されたかまたは人工的に誘導された免疫抑制後にｔ細胞免疫サーベイランスを回復もしくは増強するための方法
Bacchetta et al. Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow
Li et al. Ex vivo activated OVA specific and non-specific CD4+ CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses
SAWCHUK et al. CONTRASTING IN VIVO EFFECTS ON T HELPER CELL FUNCTIONS INDUCED BY MITOGENIC (INTACT) VERSUS NONMITOGENIC (F (ab'2) ANTI-CD3 MONOCLONAL ANTIBODY
CN1798577A (zh) 使用抗－cd52抗体诱导调节性t细胞分化和/或使调节性t细胞增殖的方法以及为此使用的药物组合物
US20100279401A1 (en) T Cell Hybridomas And Related Compositions And Methods For Assaying And Modulating T Cell Receptor-Mediated Immune Responses
Wang et al. ABSOLUTE REQUIREMENT FOR THE PD-1/PD-L1 PATHWAY FOR COSTIMULATION BLOCKADE-INDUCED ALLOGRAFT TOLERANCE.
HK1155467A (en) Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
AU2007202851A1 (en) Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040924

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040924

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070405

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070405

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20070816

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080325

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080715